CRISPR Therapeutics AG (CRSP)
49.84
-0.89
(-1.75%)
USD |
NASDAQ |
Nov 13, 16:00
49.75
-0.09
(-0.18%)
After-Hours: 20:00
CRISPR Therapeutics Total Return Level: 50.73 for Nov. 12, 2024
Total Return Level Chart
Historical Total Return Level Data
Date | Value |
---|---|
November 12, 2024 | 50.73 |
November 11, 2024 | 54.86 |
November 08, 2024 | 51.62 |
November 07, 2024 | 51.88 |
November 06, 2024 | 50.72 |
November 05, 2024 | 50.36 |
November 04, 2024 | 50.59 |
November 01, 2024 | 50.76 |
October 31, 2024 | 46.39 |
October 30, 2024 | 47.93 |
October 29, 2024 | 48.94 |
October 28, 2024 | 49.71 |
October 25, 2024 | 47.36 |
October 24, 2024 | 47.95 |
October 23, 2024 | 46.00 |
October 22, 2024 | 48.04 |
October 21, 2024 | 48.51 |
October 18, 2024 | 48.92 |
October 17, 2024 | 48.29 |
October 16, 2024 | 49.00 |
October 15, 2024 | 48.05 |
October 14, 2024 | 47.82 |
October 11, 2024 | 46.85 |
October 10, 2024 | 45.39 |
October 09, 2024 | 45.40 |
Date | Value |
---|---|
October 08, 2024 | 45.20 |
October 07, 2024 | 45.49 |
October 04, 2024 | 45.37 |
October 03, 2024 | 44.90 |
October 02, 2024 | 45.71 |
October 01, 2024 | 45.58 |
September 30, 2024 | 46.98 |
September 27, 2024 | 47.32 |
September 26, 2024 | 46.49 |
September 25, 2024 | 45.92 |
September 24, 2024 | 46.79 |
September 23, 2024 | 46.74 |
September 20, 2024 | 48.18 |
September 19, 2024 | 49.49 |
September 18, 2024 | 49.59 |
September 17, 2024 | 49.87 |
September 16, 2024 | 47.74 |
September 13, 2024 | 48.94 |
September 12, 2024 | 45.89 |
September 11, 2024 | 45.44 |
September 10, 2024 | 45.59 |
September 09, 2024 | 44.87 |
September 06, 2024 | 44.62 |
September 05, 2024 | 45.25 |
September 04, 2024 | 45.03 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
33.68
Minimum
Mar 16 2020
210.04
Maximum
Jan 14 2021
74.99
Average
63.43
Median
Jan 16 2024
Total Return Level Benchmarks
Vertex Pharmaceuticals Inc | 490.00 |
AC Immune SA | 3.06 |
Addex Therapeutics Ltd | 8.77 |
NLS Pharmaceutics Ltd | 3.90 |
Molecular Partners AG | 5.690 |